IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.

MLA

Cipolla, Ellyse, et al. “IL-17A Deficiency Mitigates Bleomycin-Induced Complement Activation during Lung Fibrosis.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 31, no. 12, Dec. 2017, pp. 5543–56. EBSCOhost, https://doi.org/10.1096/fj.201700289R.

APA

Cipolla, E., Fisher, A. J., Gu, H., Mickler, E. A., Agarwal, M., Wilke, C. A., Kim, K. K., Moore, B. B., & Vittal, R. (2017). IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 31(12), 5543–5556. https://doi.org/10.1096/fj.201700289R

Chicago

Cipolla, Ellyse, Amanda J Fisher, Hongmei Gu, Elizabeth A Mickler, Manisha Agarwal, Carol A Wilke, Kevin K Kim, Bethany B Moore, and Ragini Vittal. 2017. “IL-17A Deficiency Mitigates Bleomycin-Induced Complement Activation during Lung Fibrosis.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 31 (12): 5543–56. doi:10.1096/fj.201700289R.